FDA Drug recall D-1496-2020
Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15
- FDA Drug
- Class III
- terminated
- Published 2020-08-19
On 2020-08-19 the FDA classified a Class III recall of Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15 by Taro Pharmaceuticals U, citing failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1496-2020 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2020-07-20 |
| Published | 2020-08-19 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Taro Pharmaceuticals U |
| Distribution | US |
Product
Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For External Use Only, Not for Ophthalmic Use, Mfd by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Marketed by: Golden State Medical Supply, Inc. Camarillo, CA 93012.
Reason
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Identifiers
| code_info | a) AB28353, Exp 12/31/2021; b) AB40178, Exp 12/31/2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1496-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.